Befidi Robert 4

What Happened

• Robert Befidi, President, Diagnostics at Envista (NVST), was credited with 998 notional shares as an award/acquisition under the company's Excess Contribution Program (ECP) on February 1, 2026. The notional share price reported is $23.47, for a notional value of $23,423.
• This was an award (transaction code A) of derivative/notional shares rather than an open-market purchase or sale — not an immediate cash outlay or sale.

Key Details

• Transaction date: 2026-02-01; Filing date: 2026-02-03 (Form 4 filed timely).
• Price used: $23.47 per share; Total notional value: $23,423.
• Shares acquired: 998 notional/unfunded shares credited to the ECP stock fund.
• Shares owned after transaction: Not disclosed in the provided excerpt of the filing.
• Notable footnotes:
  • F1: Notional shares convert on a one-for-one basis to actual Envista common shares.
  • F2–F4: These shares reflect company contributions to the ECP (matching and/or non‑elective contributions) that are recorded as unfunded, notional shares. Vesting for matching contributions occurs one year after credit; non‑elective contributions vest after one year or after three years of service, whichever is later. Contributions are converted to notional share counts using the NYSE closing price on the last day of January each year.

Context

• This is a compensation-related award into a deferred compensation stock fund (ECP), not a market buy or sale. Such awards are routine components of executive compensation and are subject to the ECP’s vesting rules and conversion mechanics described above. They do not by themselves indicate a decision to buy or sell stock on the open market.